Stockreport

Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference

Olema Pharmaceuticals, Inc.  (OLMA) 
PDF SAN FRANCISCO, April 08, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company foc [Read more]